Volume 22 No 1 (2024)
 Download PDF
Role of MRI in Evaluation of Primary and Secondary Bone Tumours
Dr. Jitendra Kumar Singh, Dr.Asutosh Dave, Dr.Chinmayee Biswal, Dr.Jaival Dave
Abstract
Background This study was conductedto assess bone tumours, including primary and secondary, using magnetic resonance imaging. Methods This was a hospital-based prospective observational study conducted among 100 patients to study the MRI characteristics of bone tumours at Padmashree Dr.D.Y. Patil Medical College and Hospital and Research Centre, Pimpri, Pune, over a period of two years from September 2020 to July2022 after obtaining clearance from the institutional ethics committee and written informed consent from the study participants. Results There were 49% women and 51% men among the patients. In our patients, 38% of the tumour locations were in the femur, and 8% were in the tibia. In 99 percent of the patients, margins were present. The majority of patients (50%) had margins that were well defined, with 10% having poorly defined margins. In 50% of the patients, the MRI revealed cortical involvement and a soft-tissue component in 30% of the cases. The most common outcomes of cortical involvement were cortical destruction (8%)and outgrowth-continuation of the cortex (14%). Both joint and neurovascular involvement were absent in all individuals. 7% of patients had tumour extensions detected on their MRIs. The MRI and x-ray results showed a significant degree of agreement with respect to the tumor's soft tissue component, cortical involvement, and extension. Osteidosteoma, chondrosarcoma, giant cell tumour, ewings sarcoma, SBC, ABC, skull osteoma, metastases, non-ossifying fibroma, malignant fibrous histocytoma, fibrroid dysplasia, and chordoma were found in 8%, 17%, 21%, 9%, 3%, 4%, 3%, 4%, 3%, 16%, 2%, 1%, 2%, and 3%, respectively, according to the MRI. Conclusion MRI had 100% sensitivityto diagnose the majority of bone tumors, while it had 100% specificity in diagnosing osteosarcoma, SBC and fibrous dysplasia.
Keywords
MRI, Evaluation, Primary, Secondary,BoneTumours.
Copyright
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.